Cannara Biotech ($LOVE.V) FINS Review
Q3 2025
Some interesting cannabis stocks in the microcap space have risen to the forefront over the past year or so and Cannara Biotech is certainly more than worthy to be included within that list.
My initial review of LOVE was in early May, giving them and encouraging and watchlist worthy three stars. You can read that review below:
Coming out of their Q2, Cannara didn’t get a lot of “LOVE” with the stock sliding by 23% over the next six weeks, but after hitting a low of $1.08 back on June 11, the stock is up 66% since. Q3 financials were released yesterday morning and at first glance I thought they would have had a fantastic day, but they only finished just better than flat, up a paltry .56%. Were these numbers already priced in?